The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
154 jobs Number of planned job losses
Announcement Date
15 October 2008
Employment effect (start)
31 October 2008
Foreseen end date
31 December 2008
Description
The pharmaceutical manufacturer Janssen Pharmaceutica owns several sites in Belgium. The management announced its intention to cut an overall 154 jobs on those sites. However, no direct dismissals are foreseen and the employees would be reemployed in other units within the company. This internal restructuring was necessary because of the increasing competitive conditions of the market.
Sources
16 October 2008: La Libre Belgique
15 October 2008: Het Nieuwsblad
Citation
Eurofound (2008), Janssen Pharmaceutica, Internal restructuring in Belgium, factsheet number 67287, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67287.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
